Callan Capital, LLC Pfizer Inc Transaction History
Callan Capital, LLC
- $1.42 Billion
- Q3 2024
A detailed history of Callan Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Callan Capital, LLC holds 16,736 shares of PFE stock, worth $432,290. This represents 0.03% of its overall portfolio holdings.
Number of Shares
16,736
Previous 17,845
6.21%
Holding current value
$432,290
Previous $499,000
3.01%
% of portfolio
0.03%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding PFE
# of Institutions
3,258Shares Held
3.62BCall Options Held
77.2MPut Options Held
122M-
Vanguard Group Inc Valley Forge, PA516MShares$13.3 Billion0.27% of portfolio
-
Black Rock Inc. New York, NY424MShares$11 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.5 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA164MShares$4.23 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA130MShares$3.36 Billion0.73% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $145B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...